Riot Platforms, Inc. — Director's Dealing 2010

Apr 1, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2010-03-30

Reporting Person: HEPLER DOUGLAS I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-30	Common Stock	M	50000	$0.75	Acquired	59000	Indirect
2010-03-30	Common Stock	S	17700	$2.17	Disposed	41300	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-30	Stock option (Right to Buy)	$0.75	M	50000	Disposed	2010-03-31	Common Stock (50000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct

Footnotes

F1: Dr. Hepler's spouse exercised a stock option granted to her for service on a company advisory board. The stock option was due to expire on March 31, 2010. Dr.
Hepler disclaims beneficial ownership of the shares held by his spouse.